Figure 5From: Adherence to treatment guidelines and survival in triple-negative breast cancer: a retrospective multi-center cohort study with 9156 patients Overall survival (OAS) and disease-free survival (DFS) for TNBC patients who received 100% guideline-adherent adjuvant treatment, as stratified by age (<50 n = 164; 50–64 n = 134; ≥65 n = 73) and adjusted for year of diagnosis, tumor size, grading, nodal status, menopausal status, and comorbidities. Back to article page